# A Study to Assess the Efficacy and Safety of Vardenafil in the Treatment of Male Patients With Erectile Dysfunction

> **NCT00654914** · PHASE3 · COMPLETED · sponsor: **Bayer** · enrollment: 527 (actual)

## Conditions studied

- Erectile Dysfunction

## Interventions

- **DRUG:** Levitra (Vardenafil, BAY38-9456)

## Key facts

- **NCT ID:** NCT00654914
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-05
- **Primary completion:** 2004-02
- **Final completion:** 2004-02
- **Target enrollment:** 527 (ACTUAL)
- **Last updated:** 2014-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00654914

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00654914, "A Study to Assess the Efficacy and Safety of Vardenafil in the Treatment of Male Patients With Erectile Dysfunction". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00654914. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*